• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vistagen Therapeutics, Inc. - Common Stock (NQ:VTGN)

0.2580 +0.0088 (+3.53%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vistagen Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Why Did Vistagen Stock Tank 82% Today? ↗
December 17, 2025
Via Stocktwits
News headline image
Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder
December 17, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Appoints Nick Tressler as Chief Financial Officer
December 01, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Reports Findings on PH80’s Brain and Autonomic Effects in Women with Menopausal Hot Flashes at The Menopause Society 2025 Annual Meeting
November 26, 2025
From Vistagen
Via Business Wire
News headline image
Earnings Scheduled For November 13, 2025 ↗
November 13, 2025
 
Via Benzinga
News headline image
Earnings Scheduled For August 7, 2025 ↗
August 07, 2025
 
Via Benzinga
News headline image
Insights into VistaGen Therapeutics's Upcoming Earnings ↗
June 16, 2025
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
November 17, 2025
 
Via Benzinga
News headline image
Vistagen (VTGN) Q2 2026 Earnings Call Transcript ↗
November 14, 2025
Vistagen (VTGN) Q2 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Vistagen Reports Fiscal Year 2026 Second Quarter Financial Results and Provides Corporate Update
November 13, 2025
From Vistagen
Via Business Wire
News headline image
Examining the Future: VistaGen Therapeutics's Earnings Outlook ↗
November 12, 2025
 
Via Benzinga
News headline image
Vistagen to Report Fiscal Year 2026 Second Quarter Results and Host Corporate Update Conference Call on November 13, 2025
November 10, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen to Participate in Stifel Healthcare Conference 2025
November 05, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Completes PALISADE-3 Phase 3 Public Speaking Challenge Study for the Acute Treatment of Social Anxiety Disorder
November 03, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Appoints Paul Edick to its Board of Directors
October 29, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at The Menopause Society 2025 Annual Meeting
October 16, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at the TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
September 09, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen (VTGN) Q1 R&D Expense Jumps 54% ↗
August 07, 2025
Via The Motley Fool
News headline image
Vistagen Reports Fiscal Year 2026 First Quarter Financial Results and Corporate Update
August 07, 2025
From Vistagen
Via Business Wire
News headline image
Insights Ahead: VistaGen Therapeutics's Quarterly Earnings ↗
August 06, 2025
 
Via Benzinga
News headline image
Vistagen to Report Fiscal Year 2026 First Quarter Results and Host Corporate Update Conference Call on August 7, 2025
July 31, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at the BTIG Virtual Biotechnology Conference
July 24, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Honored for Outstanding Workplace Culture and Mental Health Leadership
July 15, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Appoints Elissa Cote as Chief Corporate Development Officer
June 25, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen Reports Fiscal Year 2025 Financial Results and Provides Corporate Update
June 17, 2025
From Vistagen
Via Business Wire
News headline image
Earnings Scheduled For June 17, 2025 ↗
June 17, 2025
 
Via Benzinga
News headline image
Vistagen to Report Fiscal Year 2025 Financial Results and Host Corporate Update Conference Call on June 17, 2025
June 12, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen on Track to Deliver Topline Data From Fasedienol PALISADE-3 Phase 3 Trial for Acute Treatment of Social Anxiety Disorder in the Fourth Quarter of This Year
June 02, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at the Jefferies 2025 Global Life Sciences Conference New York
May 28, 2025
From Vistagen
Via Business Wire
News headline image
Vistagen to Present at the 2025 American Society of Clinical Psychopharmacology Conference
May 23, 2025
From Vistagen
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap